A Combination Immunosuppression Treatment with Bortezomib and an Anti-CD20 mAb Enables Successful Re-Administration of AAV8 Vector in Mice
Conferences
Choi, SJ; Yi, J; Tedder, TF; Koeberl, DD; Kishnani, PS; Sun, B
Published in: MOLECULAR THERAPY
April 28, 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
April 28, 2020
Volume
28
Issue
4
Start / End Page
521 / 521
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
Citation
APA
Chicago
ICMJE
MLA
NLM
Choi, S. J., Yi, J., Tedder, T. F., Koeberl, D. D., Kishnani, P. S., & Sun, B. (2020). A Combination Immunosuppression Treatment with Bortezomib and an Anti-CD20 mAb Enables Successful Re-Administration of AAV8 Vector in Mice. In MOLECULAR THERAPY (Vol. 28, pp. 521–521).
Choi, Su Jin, John Yi, Thomas F. Tedder, Dwight D. Koeberl, Priya S. Kishnani, and Baodong Sun. “A Combination Immunosuppression Treatment with Bortezomib and an Anti-CD20 mAb Enables Successful Re-Administration of AAV8 Vector in Mice.” In MOLECULAR THERAPY, 28:521–521, 2020.
Choi SJ, Yi J, Tedder TF, Koeberl DD, Kishnani PS, Sun B. A Combination Immunosuppression Treatment with Bortezomib and an Anti-CD20 mAb Enables Successful Re-Administration of AAV8 Vector in Mice. In: MOLECULAR THERAPY. 2020. p. 521–521.
Choi, Su Jin, et al. “A Combination Immunosuppression Treatment with Bortezomib and an Anti-CD20 mAb Enables Successful Re-Administration of AAV8 Vector in Mice.” MOLECULAR THERAPY, vol. 28, no. 4, 2020, pp. 521–521.
Choi SJ, Yi J, Tedder TF, Koeberl DD, Kishnani PS, Sun B. A Combination Immunosuppression Treatment with Bortezomib and an Anti-CD20 mAb Enables Successful Re-Administration of AAV8 Vector in Mice. MOLECULAR THERAPY. 2020. p. 521–521.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
April 28, 2020
Volume
28
Issue
4
Start / End Page
521 / 521
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics